Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China; The First Department of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.
Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Biomed Pharmacother. 2020 Mar;123:109780. doi: 10.1016/j.biopha.2019.109780. Epub 2019 Dec 31.
FAM83A is part of an 8-member protein family of unknown function and is reported to be a cancer-promoting and treatment-resistance factor in several cancers. However, its role in hepatocellular carcinoma (HCC) remains unclear. Analysis of the Cancer Genome Atlas (TCGA) showed that FAM83A mRNA expression is upregulated in HCC, as are the protein expression levels in both HCC cell lines and tissues. Clinical data have demonstrated that high FAM83A expression is positively correlated with poor progression-free survival time, thus suggesting its cancer-promoting potential. Functional analyses showed that FAM83A overexpression promoted HCC cell migration and invasion in vitro and suppressed sorafenib sensitivity. Inhibiting FAM83A reversed these results. A pulmonary metastasis model further confirmed that FAM83A promoted HCC cell metastasis in vivo. Mechanistic analyses indicated that FAM83A activated the PI3K/AKT signaling pathway, its downstream c-JUN protein, and epithelial-to-mesenchymal transition (EMT)-related protein levels, including downregulation of E-cadherin and upregulation of Vimentin and N-cadherin. Interestingly, c-JUN induced FAM83A expression by directly binding to its promoter region and thus forming a positive-feedback loop for FAM83A/PI3K/AKT/c-JUN. In conclusion, we demonstrated that FAM83A, as a cancer-metastasis promoter, accelerates migration, invasion and metastasis by activating the PI3K/AKT/c-JUN pathway and inducing its self-expression via feedback, thus forming a FAM83A/PI3K/AKT/c-JUN positive-feedback loop to activate EMT signaling and finally promote HCC migration, invasion and metastasis.
FAM83A 是一个未知功能的 8 成员蛋白家族的一部分,据报道,它在几种癌症中是促进癌症发展和治疗耐药的因素。然而,其在肝细胞癌 (HCC) 中的作用尚不清楚。对癌症基因组图谱 (TCGA) 的分析表明,FAM83A mRNA 在 HCC 中表达上调,HCC 细胞系和组织中的蛋白表达水平也是如此。临床数据表明,高 FAM83A 表达与无进展生存期短呈正相关,因此表明其具有促进癌症的潜力。功能分析表明,FAM83A 过表达促进 HCC 细胞在体外的迁移和侵袭,并抑制索拉非尼的敏感性。抑制 FAM83A 逆转了这些结果。肺部转移模型进一步证实 FAM83A 促进 HCC 细胞在体内的转移。机制分析表明,FAM83A 激活了 PI3K/AKT 信号通路及其下游的 c-JUN 蛋白以及上皮间质转化 (EMT) 相关蛋白水平,包括下调 E-钙粘蛋白和上调波形蛋白和 N-钙粘蛋白。有趣的是,c-JUN 通过直接结合其启动子区域诱导 FAM83A 表达,从而形成 FAM83A/PI3K/AKT/c-JUN 的正反馈回路。总之,我们证明 FAM83A 作为一种促进癌症转移的蛋白,通过激活 PI3K/AKT/c-JUN 通路和通过反馈诱导自身表达来加速迁移、侵袭和转移,从而形成 FAM83A/PI3K/AKT/c-JUN 正反馈回路来激活 EMT 信号,最终促进 HCC 的迁移、侵袭和转移。